Holdings of Schwab Health Care Fund
SCHWAB CAPITAL TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 642.3M $ including 635.8M $ in equities, 99.0 %
- Positions
- 80 in 14 countries
- Top ten
- 49.9 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 77,841 | 89.4M $ | 13.92 % |
| 2 | Johnson & Johnson | 173,926 | 44.6M $ | 6.94 % |
| 3 | AbbVie Inc | 148,742 | 37.3M $ | 5.81 % |
| 4 | Merck & Co Inc | 245,830 | 32M $ | 4.98 % |
| 5 | UnitedHealth Group Inc | 73,427 | 30.4M $ | 4.74 % |
| 6 | Gilead Sciences Inc | 159,968 | 20.8M $ | 3.24 % |
| 7 | Novartis AG | 120,049 | 18.8M $ | 2.92 % |
| 8 | Amgen Inc | 43,091 | 16.6M $ | 2.58 % |
| 9 | Bristol-Myers Squibb Co | 240,303 | 15.7M $ | 2.44 % |
| 10 | Medtronic PLC | 172,333 | 14.7M $ | 2.29 % |
| 11 | Roche Holding AG | 33,618 | 14.7M $ | 2.29 % |
| 12 | Thermo Fisher Scientific Inc | 24,108 | 13.8M $ | 2.16 % |
| 13 | Stryker Corp | 41,586 | 13.5M $ | 2.11 % |
| 14 | Vertex Pharmaceuticals Inc | 25,379 | 12.1M $ | 1.89 % |
| 15 | GSK PLC | 427,052 | 11.1M $ | 1.73 % |
| 16 | Boston Scientific Corp | 220,408 | 10.3M $ | 1.60 % |
| 17 | Abbott Laboratories | 97,408 | 10.3M $ | 1.60 % |
| 18 | Cigna Group/The | 34,774 | 9.7M $ | 1.51 % |
| 19 | Danaher Corp | 48,332 | 9.4M $ | 1.47 % |
| 20 | Elevance Health Inc | 24,845 | 9.3M $ | 1.45 % |
| 21 | Incyte Corp | 73,854 | 8.8M $ | 1.37 % |
| 22 | Ipsen SA | 44,466 | 8.6M $ | 1.34 % |
| 23 | Sanofi SA | 97,498 | 8.4M $ | 1.31 % |
| 24 | Becton Dickinson & Co | 48,036 | 8M $ | 1.24 % |
| 25 | Astellas Pharma Inc | 555,400 | 7.6M $ | 1.19 % |
| 26 | JAZZ PHARMACEUTICALS PLC | 29,378 | 7.4M $ | 1.16 % |
| 27 | AstraZeneca PLC | 42,820 | 7.3M $ | 1.13 % |
| 28 | McKesson Corp | 8,050 | 6.9M $ | 1.07 % |
| 29 | STERIS PLC | 28,872 | 6.6M $ | 1.03 % |
| 30 | IQVIA Holdings Inc | 27,860 | 6.5M $ | 1.02 % |
| 31 | Cardinal Health Inc | 28,069 | 6.5M $ | 1.01 % |
| 32 | HealthEquity Inc | 62,072 | 6.2M $ | 0.97 % |
| 33 | CVS Health Corp | 58,631 | 6.1M $ | 0.95 % |
| 34 | Exelixis Inc | 111,637 | 5.9M $ | 0.92 % |
| 35 | United Therapeutics Corp | 11,322 | 5.9M $ | 0.91 % |
| 36 | IDEXX Laboratories Inc | 10,363 | 5.8M $ | 0.90 % |
| 37 | ResMed Inc | 25,092 | 5.3M $ | 0.82 % |
| 38 | HCA Healthcare Inc | 12,961 | 5.2M $ | 0.81 % |
| 39 | BRIGHTSPRING HEALTH SERVICES INC | 79,281 | 4.7M $ | 0.74 % |
| 40 | Regeneron Pharmaceuticals Inc | 6,059 | 4.6M $ | 0.72 % |
| 41 | Koninklijke Philips NV | 174,278 | 4.6M $ | 0.71 % |
| 42 | Neurocrine Biosciences Inc | 26,394 | 4.4M $ | 0.69 % |
| 43 | Veracyte Inc | 87,202 | 4M $ | 0.63 % |
| 44 | Agilent Technologies Inc | 27,455 | 3.8M $ | 0.59 % |
| 45 | Hoya Corp | 24,000 | 3.7M $ | 0.57 % |
| 46 | ANI Pharmaceuticals Inc | 43,420 | 3.4M $ | 0.54 % |
| 47 | BioMarin Pharmaceutical Inc | 49,405 | 3M $ | 0.46 % |
| 48 | Innoviva Inc | 131,747 | 2.8M $ | 0.43 % |
| 49 | Axsome Therapeutics Inc | 12,357 | 2.7M $ | 0.42 % |
| 50 | Smith & Nephew PLC | 168,675 | 2.6M $ | 0.41 % |
| 51 | NATERA INC | 9,725 | 2.6M $ | 0.41 % |
| 52 | Intuitive Surgical Inc | 7,152 | 2.5M $ | 0.39 % |
| 53 | Ascendis Pharma A/S | 9,761 | 2.4M $ | 0.37 % |
| 54 | Align Technology Inc | 13,600 | 2.3M $ | 0.36 % |
| 55 | Novo Nordisk A/S | 45,699 | 2.2M $ | 0.34 % |
| 56 | Asahi Intecc Co Ltd | 90,900 | 2.1M $ | 0.32 % |
| 57 | BioCryst Pharmaceuticals Inc | 175,900 | 1.6M $ | 0.25 % |
| 58 | Ambea AB | 94,458 | 1.4M $ | 0.22 % |
| 59 | Universal Health Services Inc | 8,100 | 1.4M $ | 0.21 % |
| 60 | Krystal Biotech Inc | 3,714 | 1.3M $ | 0.20 % |
| 61 | TRAVERE THERAPEUTICS INC | 22,405 | 1.3M $ | 0.20 % |
| 62 | Chugai Pharmaceutical Co Ltd | 28,000 | 1.2M $ | 0.19 % |
| 63 | Pegavision Corp | 120,000 | 1.2M $ | 0.19 % |
| 64 | Biogen Inc | 5,732 | 1.2M $ | 0.18 % |
| 65 | Aurinia Pharmaceuticals Inc | 75,100 | 1.1M $ | 0.17 % |
| 66 | Fisher & Paykel Healthcare Corp Ltd | 40,000 | 956.7K $ | 0.15 % |
| 67 | Amneal Pharmaceuticals Inc | 50,864 | 931.8K $ | 0.15 % |
| 68 | Dexcom Inc | 9,200 | 767.7K $ | 0.12 % |
| 69 | Halozyme Therapeutics Inc | 8,998 | 742.7K $ | 0.12 % |
| 70 | Liquidia Corp | 8,240 | 693.1K $ | 0.11 % |
| 71 | Hikma Pharmaceuticals PLC | 30,760 | 656.7K $ | 0.10 % |
| 72 | AnaptysBio Inc | 11,939 | 637.1K $ | 0.10 % |
| 73 | Hugel Inc | 3,776 | 609K $ | 0.09 % |
| 74 | Xeris Biopharma Holdings Inc | 51,241 | 414K $ | 0.06 % |
| 75 | Consun Pharmaceutical Group Ltd | 193,000 | 337.3K $ | 0.05 % |
| 76 | Medipal Holdings Corp | 17,900 | 322.3K $ | 0.05 % |
| 77 | Attendo AB | 25,000 | 287.5K $ | 0.04 % |
| 78 | MIRUM PHARMACEUTICALS INC | 2,435 | 258K $ | 0.04 % |
| 79 | Elekta AB | 49,962 | 254.2K $ | 0.04 % |
| 80 | GE HealthCare Technologies Inc | 2,800 | 190.5K $ | 0.03 % |
Sector breakdown
- Health care 84.4 %
- Unattributed 15.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 84.5 %
- CHF 5.3 %
- GBP 3.4 %
- EUR 3.4 %
- JPY 2.3 %
- DKK 0.3 %
- SEK 0.3 %
- TWD 0.2 %
- NZD 0.2 %
- KRW 0.1 %
- HKD 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 82.7 %
- Switzerland 5.3 %
- United Kingdom 3.4 %
- France 2.7 %
- Japan 2.3 %
- Ireland 1.2 %
- Netherlands 0.7 %
- Denmark 0.7 %
- Sweden 0.3 %
- Taiwan 0.2 %
- Canada 0.2 %
- New Zealand 0.2 %
- Other countries 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 55 | 526M $ | 82.73 % |
| 2 | Switzerland | 2 | 33.5M $ | 5.26 % |
| 3 | United Kingdom | 4 | 21.7M $ | 3.41 % |
| 4 | France | 2 | 17M $ | 2.67 % |
| 5 | Japan | 5 | 14.9M $ | 2.34 % |
| 6 | Ireland | 1 | 7.4M $ | 1.17 % |
| 7 | Netherlands | 1 | 4.6M $ | 0.72 % |
| 8 | Denmark | 2 | 4.5M $ | 0.71 % |
| 9 | Sweden | 3 | 2M $ | 0.31 % |
| 10 | Taiwan | 1 | 1.2M $ | 0.19 % |
| 11 | Canada | 1 | 1.1M $ | 0.18 % |
| 12 | New Zealand | 1 | 956.7K $ | 0.15 % |
Cite this page
Titelia. "Holdings of Schwab Health Care Fund". https://titelia.com/en/funds/S000005519